Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$1.93 | -$0.12 | -$1.03 |
Q2 2024 | 1 | -$2.36 | -$0.15 | -$1.25 |
Q3 2024 | 1 | -$2.41 | -$0.15 | -$1.28 |
Q4 2024 | 1 | -$1.75 | -$0.11 | -$0.93 |
Q1 2025 | 1 | -$3.39 | -$0.21 | -$1.80 |
Q2 2025 | 1 | -$3.58 | -$0.22 | -$1.90 |
Q3 2025 | 1 | -$3.77 | -$0.23 | -$2.00 |
Q4 2025 | 1 | -$3.77 | -$0.23 | -$2.00 |
HOOKIPA Pharma Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-1.1 earnings per share for the quarter, topping analysts' consensus estimates of $-1.28 by $0.18. The company had revenue of 4.70 M for the quarter and had revenue of 20.13 M for the year. HOOKIPA Pharma Inc. has generated $-9 earnings per share over the last year ($-8.63 diluted earnings per share) and currently has a price-to-earnings ratio of -0.58. HOOKIPA Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$1.28 | -$1.10 | 0.18 | $6.25 M | $4.70 M |
08/08/2024 | Q2 2024 | -$1.44 | -$1.52 | -0.08 | $7.10 M | $1.29 M |
05/09/2024 | Q1 2024 | -$1.20 | $1.10 | 2.3 | $36.60 M | |
03/22/2024 | Q4 2023 | -$2.00 | -$2.51 | -0.51 | $7.41 M | |
11/09/2023 | Q3 2023 | -$2.30 | -$1.73 | 0.57 | $4.25 M | $6.87 M |
08/10/2023 | Q2 2023 | -$2.10 | -$2.18 | -0.08 | $4.87 M | $2.68 M |
05/11/2023 | Q1 2023 | -$2.40 | -$2.73 | -0.33 | $3.18 M | |
03/15/2023 | Q4 2022 | -$1.80 | -$2.25 | -0.45 | $7.83 M | |
11/14/2022 | Q3 2022 | -$2.40 | -$0.25 | 2.15 | $2.91 M | $2.23 M |
08/11/2022 | Q2 2022 | -$3.60 | -$0.23 | 3.37 | $3.36 M | $2.75 M |
05/16/2022 | Q1 2022 | -$1.20 | -$0.40 | 0.8 | $1.45 M | |
03/24/2022 | Q4 2021 | -$5.30 | -$0.65 | 4.65 | $3.90 M | |
11/10/2021 | Q3 2021 | -$5.40 | -$0.61 | 4.79 | $5.72 M | $3.87 M |
08/12/2021 | Q2 2021 | -$5.20 | -$0.52 | 4.68 | $5.12 M | $5.38 M |
05/12/2021 | Q1 2021 | -$5.30 | -$0.53 | 4.77 | $5.30 M | |
03/18/2021 | Q4 2020 | -$5.60 | -$0.46 | 5.14 | $5.16 M | |
11/12/2020 | Q3 2020 | -$4.20 | -$0.53 | 3.67 | $4.61 M | $4.04 M |
08/13/2020 | Q2 2020 | -$4.60 | -$0.28 | 4.32 | $3.49 M | $6.69 M |
05/14/2020 | Q1 2020 | -$3.90 | -$0.43 | 3.47 | $3.70 M | |
03/19/2020 | Q4 2019 | -$4.30 | -$0.40 | 3.9 | $3.62 M |
HOOKIPA Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
In the previous quarter, HOOKIPA Pharma Inc. (:HOOK) reported $-1.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.28 by $0.18.
The conference call for HOOKIPA Pharma Inc.'s latest earnings report can be listened to online.
The conference call transcript for HOOKIPA Pharma Inc.'s latest earnings report can be read online.
HOOKIPA Pharma Inc. (:HOOK) has a recorded annual revenue of $20.13 M.
HOOKIPA Pharma Inc. (:HOOK) has a recorded net income of $20.13 M. HOOKIPA Pharma Inc. has generated $-8.63 earnings per share over the last four quarters.
HOOKIPA Pharma Inc. (:HOOK) has a price-to-earnings ratio of -0.58 and price/earnings-to-growth ratio is -0.04.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED